Clinical Trial Update: Continuous Infusion Piperacillin-tazobactam for the Treatment of Cystic Fibrosis [Phase 4]

View source ↗

Summary

Phase 4 trial update on continuous infusion piperacillin-tazobactam for cystic fibrosis; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Piperacillin/tazobactam (Piperacillin/tazobactam)

Snippet

Sponsor: West Virginia University | Conditions: Cystic Fibrosis | Phase 4 | Status: TERMINATED | Results posted: 2022-02-01